K896926

Substantially Equivalent

DIRECTIGEN 1-2-3 INFECTIOUS MONONUCLEOSIS CONTROLS

Applicant: Quidel Corp.
Product code: KTN
Advisory panel: Immunology
Date received: 1989-12-11
Decision date: 1990-01-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.